Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors (pages 23–31)Taito Esaki, Takashi Seto, Hiroshi Ariyama, Shuji Arita, Chinatsu Fujimoto, Koichiro Tsukasa, Takuro Kometani, Kaname Nosaki, Fumihiko Hirai and Katsuro Yagawa
Article first published online: 7 APR 2011 | DOI: 10.1111/j.1753-5174.2011.00034.x